thank you

Home » thank you

Thanks for subscribing!

Search for:

Recent Myeloma Articles

STRO-001 Receives FDA’s Orphan Drug Status for Multiple Myeloma Treatment

October 22, 2018
Selinexor Granted Priority Review by FDA for Heavily Treated Multiple Myeloma

October 19, 2018
Most Blood Cancer Patients Don’t Fully Understand Their Diagnosis, Survey in England Reveals

October 17, 2018
FDA Clears ClonoSEQ Assay for Measuring Minimal Residual Disease in Myeloma, Leukemia

October 15, 2018
Combination of Reolysin, Opdivo, and Standard of Care to Be Tested in Phase 1 Trial for Multiple Myeloma

October 12, 2018
Once-weekly Kyprolis with Dexamethasone Approved in US for Relapsed or Refractory Multiple Myeloma

October 10, 2018
Takeda, Molecular Templates Partner to Develop Next-generation IO for Multiple Myeloma

October 8, 2018
EMA Begins Review Process for Empliciti Triple Combo for Relapsed or Refractory Multiple Myeloma

October 3, 2018
Karyopharm’s Selinexor Demonstrates High Response Rates in Heavily-treated Multiple Myeloma Patients

September 28, 2018

Myeloma Research News

BioNews Services, LLC
3 W. Garden St.
Suite 354
Pensacola, FL 32502
Email: [email protected]
Phone: 1-800-936-1363

About Us
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Myeloma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. Ok Read more